Yes, my understanding also is that Cvac works, however it...

Yes, my understanding also is that Cvac works, however it doesn't work an all patients or all cancer mutations ( there are more than 1). But then again, the FDA never expects a drug to work 100% of the time on all patients. Cvac aims to meet an unmet need on patients that would otherwise have the most radical of treatments with a very poor prognosis anyway.

And if you go back and review the last Investor Presentation ( this month), it compares the efficacy they have already found to other comparable vaccines of Cvac, & they have so far found that Cvac works BETTER than these, already on market.

My understanding is that they are doing these large trials now to get the results needed so that they won't need to redo any further trials - which is expensive & time consuming ( but much better in the long run - especially for patients).

I am very confident, and would not have invested if I wasn't over 90% confident that MR & his team know exactly what they are doing!!!

Spare Paper